Reports
Sale
Global 3D Bioprinted Human Tissue Market Size, Share, Trends: By Tissue Type: Skin, Cartilage, Liver, Bone, Heart, Others; By Technology: Inkjet-based Bioprinting, Extrusion-based Bioprinting, Laser-assisted Bioprinting, Magnetic Bioprinting; By Applications: Drug Discovery, Others; By End User; Regional Analysis; Supplier Landscape; 2024-2032
Global 3D Bioprinted Human Tissue Market Outlook
The global 3D bioprinted human tissue market size was valued at USD 2.3 billion in 2023, driven by growing investments in biotechnology research and development across the globe. The market is expected to grow at a CAGR of 8.4% during the forecast period of 2024-2032, with the values likely to rise from USD 2.5 billion in 2024 to USD 4.8 billion by 2032.
3D Bioprinted Human Tissue: Introduction
3D bioprinted human tissues are artificially manufactured functional tissues that mimic the function and architecture of native tissues. They are developed using layer-by-layer deposition of living cells, growth factors and biomaterials. 3D bioprinted human tissues are widely used in regenerative medicine providing the potential for creating organs and personalized tissues for transplantation along with drug discovery, research, and cosmetic surgeries, among others.
Global 3D Bioprinted Human Tissue Market Analysis
The 3D bioprinted human tissue market demand has grown significantly in recent years owing to its increasing application in replacing human tissues, creating biomaterial skin for wounds, skin grafting and printing living skin with blood vessels.
With rising technical advancements in biotechnology, the researchers aim at offering better techniques for quality tissue development. Digital light processing (DLP) 3D bioprinting, developed by the University of California research team is one of the latest methods used for creating a vascularized tissue that operates as a human-like living cell with biomaterial structures. There is significant development in bioinks as well, wherein HU3DINKS project has been launched by BIO INX to replace animal based bioink with human bioink is a key area of attention.
3D bioprinted human tissues showcase commercial adaptability, high experimental reproducibility, as well as industrial scalability. Consequently, it is a major area of interest amongst investors. In July 2023, 3D BioFibR, a Canadian tissue engineering company, received a USD 3.52 million funding to expand the company’s profile and develop diameter-controlled collagen fibers at a commercial scale. Such investments demonstrate that the 3D bioprinted human tissue market growth is anticipated to witness further growth in upcoming years.
Global 3D Bioprinted Human Tissue Market Segmentation
Market Breakup by Tissue Type
- Skin
- Cartilage
- Liver
- Bone
- Heart
- Others
Market Breakup by Technology
- Inkjet-based Bioprinting
- Extrusion-based Bioprinting
- Laser-assisted Bioprinting
- Magnetic Bioprinting
Market Breakup by Applications
- Drug Discovery
- Regenerative Medicine
- Research
- Cosmetic Surgery
- Others
Market Breakup by End User
- Pharmaceutical and Biotechnology Companies
- Research Institutes and Academic Centers
- Hospitals and Clinics
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global 3D Bioprinted Human Tissue Market Overview
North America, led by the United States and Canada, is anticipated to lead the 3D bioprinted human tissue market share. The market is primarily driven by rising government initiatives and investments to foster innovation in biotechnology research. In March 2023, the Government of Canada invested approximately USD 25.7 million in Aspect Biosystems, a coming-of-age biotechnology firm.
Europe is another significant player in the market with numerous academic institutions and biotechnology companies at home. The market growth can be attributed to increasing partnerships between prominent companies and institutes to develop advanced developments in the field.
Owing to the presence of economic resources and high percentage of academically talented youth, the Asia Pacific 3D bioprinted human tissue market value is projected to grow further in the forecast period. Apart from foreign investments, the government of emerging economies such as India, South Korea, and Taiwan are taking critical initiatives aimed at improving the healthcare and research infrastructure.
Global 3D Bioprinted Human Tissue Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- 3D Systems, Inc.
- Materialise NV
- Oceanz 3D printing
- Organovo
- Prellis Biologics
- SOLS Systems
- Stratasys Ltd
- The Pexion Group
- Allevi, Inc.
- Aspect Biosystems Ltd.
- Biolife 4D
- Cellbricks
- Cellink
- Microdrop
- MicroFab Technologies Inc.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Tissue Type |
|
| Breakup by Technology |
|
| Breakup by Applications |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global 3D Bioprinted Human Tissue Market Overview
3.1 Global 3D Bioprinted Human Tissue Market Historical Value (2017-2023)
3.2 Global 3D Bioprinted Human Tissue Market Forecast Value (2024-2032)
4 Global 3D Bioprinted Human Tissue Market Landscape
4.1 Global 3D Bioprinted Human Tissue Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global 3D Bioprinted Human Tissue Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Technology
4.2.3 Analysis by Applications
5 Global 3D Bioprinted Human Tissue Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global 3D Bioprinted Human Tissue Market Segmentation
6.1 Global 3D Bioprinted Human Tissue Market by Tissue Type
6.1.1 Market Overview
6.1.2 Skin
6.1.3 Cartilage
6.1.4 Liver
6.1.5 Bone
6.1.6 Heart
6.1.7 Others
6.2 Global 3D Bioprinted Human Tissue Market by Technology
6.2.1 Market Overview
6.2.2 Inkjet-based Bioprinting
6.2.3 Extrusion-based Bioprinting
6.2.4 Laser-assisted Bioprinting
6.2.5 Magnetic Bioprinting
6.3 Global 3D Bioprinted Human Tissue Market by Applications
6.3.1 Market Overview
6.3.2 Drug Discovery
6.3.3 Regenerative Medicine
6.3.4 Research
6.3.5 Cosmetic Surgery
6.3.6 Others
6.4 Global 3D Bioprinted Human Tissue Market by End User
6.4.1 Market Overview
6.4.2 Pharmaceutical and Biotechnology Companies
6.4.3 Research Institutes and Academic Centers
6.4.4 Hospitals and Clinics
6.4.5 Others
6.5 Global 3D Bioprinted Human Tissue Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America 3D Bioprinted Human Tissue Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe 3D Bioprinted Human Tissue Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific 3D Bioprinted Human Tissue Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America 3D Bioprinted Human Tissue Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa 3D Bioprinted Human Tissue Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 3D Systems, Inc.
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisition
17.1.5 Certifications
17.2 Materialise NV
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisition
17.2.5 Certifications
17.3 Oceanz 3D printing
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisition
17.3.5 Certifications
17.4 Organovo
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisition
17.4.5 Certifications
17.5 Prellis Biologics
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisition
17.5.5 Certifications
17.6 SOLS Systems
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisition
17.6.5 Certifications
17.7 Stratasys Ltd
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisition
17.7.5 Certifications
17.8 The Pexion Group
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisition
17.8.5 Certifications
17.9 Allevi, Inc.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisition
17.9.5 Certifications
17.10 Aspect Biosystems Ltd.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisition
17.10.5 Certifications
17.11 Biolife 4D
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisition
17.11.5 Certifications
17.12 Cellbricks
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisition
17.12.5 Certifications
17.13 Cellink
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisition
17.13.5 Certifications
17.14 Microdrop
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisition
17.14.5 Certifications
17.15 MicroFab Technologies Inc.
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisition
17.15.5 Certifications
18 Global 3D Bioprinted Human Tissue Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The market attained a value of about USD 2.3 billion in 2023, driven by the increasing investments in biotechnology research and development across the globe.
The market is anticipated to grow at a CAGR of 8.4% during the forecast period of 2024-2032, likely to reach a market value of USD 4.8 billion by 2032.
The market demand is driven by growing drug development and testing activities, coupled with strong preference for personalised medicines across the globe.
The major market trend involves the emphasis on improving and bringing in new techniques for better patient outcomes. For example, BIO INX launched the HU3DINKS project that aims replacing animal based bioink with human based bioink.
Based on tissue types, the market is divided into skin, cartilage, liver, bone, and heart, among others.
Inkjet-based bioprinting, extrusion-based bioprinting, laser-assisted bioprinting, and magnetic bioprinting are common technologies available in the market.
Common application areas include drug discovery, regenerative medicine, research, and cosmetic surgery, among others.
Major end users include pharmaceutical and biotechnology companies, research institutes and academic centres, hospitals and clinics, among others.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America is currently leading the global market.
Key players involved in the market are 3D Systems, Inc., Materialise NV, Oceanz 3D printing, Organovo, Prellis Biologics, SOLS Systems, Stratasys Ltd., The Pexion Group, Allevi, Inc., Aspect Biosystems Ltd., Biolife 4D, Cellbricks, Cellink, Microdrop, and MicroFab Technologies Inc.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER